The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDH.L Regulatory News (IDH)

  • There is currently no data for IDH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

3 Feb 2015 07:00

RNS Number : 8398D
Immunodiagnostic Systems Hldgs PLC
03 February 2015
 



 

 

RNS Announcement

3 February 2015

 

Immunodiagnostic Systems Holdings plc

Patricio Lacalle Appointed New Chief Executive Officer

Immunodiagnostic Systems Holdings plc ("IDS"), a leading producer of manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets quoted on AIM, today announces that Patricio Lacalle has been appointed Chief Executive Officer and will join IDS as a Director effective 1 April 2015.

Patricio is currently the CEO of Pulsion Medical Systems SE, a medical technology company with a leading market position in hemodynamic monitoring. In the four years which he has spent at Pulsion Patricio and his team were able to lead the company to international growth while significantly expanding the operating margin. Before Pulsion Patricio held a number of management positions at Forbo Adhesives and HB Fuller.

On 1 April 2015, Burkhard Wittek, Executive Chairman, will revert to being Non-Executive Chairman.

Dr Burkhard Wittek, Executive Chairman of Immunodiagnostic Systems, said "IDS is delighted to announce the appointment of Patricio as Chief Executive Officer. We have worked together at Pulsion and were able to build a company setting standards of business quality in its field. Patricio brings to IDS a strong business sense, a bias for action and great team building and leadership skills. Our leadership team at IDS is looking forward to working with Patricio and together achieving our ambitions for driving growth and profitability."

The following disclosures are made in accordance with AIM rule 17 and Schedule 2 paragraph (g) of the AIM Rules:

Carlos Patricio Lacalle Zando, aged 49 is currently a director of Pulsion Medical Systems SE, Germany, Pulsion Medical UK Ltd., Pulsion France S.A.R.L., Pulsion Austria GmbH, Pulsion Medical Inc., USA, Pulsion Benelux N.V., Belgium, Pulsion Pacific PTY., Australia, Pulsion Switzerland GmbH, Pulsion Poland Sp.z.o.o., Pulsion Iberica S.L, Spain, Pulsion Medical Systems S. de RL de CV, Mexico, Pulsion Medical Systems Medikal Ürünler Ticaret Limited Sirketi, Turkey and in the previous five years he has also been a director of Forbo Adhesives Deutschland GmbH and Forbo Adhesives Schweiz AG.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUGUQAPUPAPUP
Date   Source Headline
14th Dec 20127:00 amRNSDirectorate Change
12th Dec 20124:00 pmRNSHolding(s) in Company
12th Dec 20127:00 amRNSHolding(s) in Company
10th Dec 20126:08 pmRNSHolding(s) in Company
30th Nov 20126:15 pmRNSDirector/PDMR Shareholding
26th Nov 20127:00 amRNSHalf Yearly Report
24th Oct 201210:59 amRNSNotice of Results
19th Oct 20127:00 amRNSDirectorate Change Update
17th Oct 201211:41 amRNSSettlement on Escalon debt
1st Oct 201210:31 amRNSHolding(s) in Company
17th Sep 201212:54 pmRNSRedirectorate
14th Sep 20126:09 pmRNSAGM Result
14th Sep 20127:00 amRNSAGM Statement
15th Aug 20127:00 amRNSBoard Change
3rd Aug 20122:33 pmRNSDirector/PDMR Shareholding
30th Jul 201210:18 amRNSHolding(s) in Company
27th Jul 20129:29 amRNSHolding(s) in Company
27th Jul 20129:24 amRNSHolding(s) in Company
26th Jul 201210:30 amRNSAnnual Report and Accounts & Notice of AGM
2nd Jul 20127:00 amRNSDirectorate Change
25th Jun 20127:00 amRNSFinal Results
14th Jun 20127:00 amRNSProduct Launch
23rd Apr 201211:02 amRNSIDS Receives Prestigious Queens Award
12th Apr 20127:00 amRNSTrading Statement
4th Apr 20129:56 amRNSHolding(s) in Company
4th Apr 20127:00 amRNS1,25-Dihydroxy Vitamin D Assay Launch
14th Feb 20127:00 amRNSFDA clearance for a new specialist assay
9th Feb 20127:00 amRNSChange of Adviser
1st Feb 20123:16 pmRNSChange of Adviser
30th Jan 20128:27 amRNSDirector/PDMR Shareholding - Replacement
30th Jan 20127:00 amRNSDirector/PDMR Shareholding
30th Jan 20127:00 amRNSDirector/PDMR Shareholding
27th Jan 20127:00 amRNSDirector/PDMR Shareholding
24th Jan 20123:18 pmRNSHolding(s) in Company
24th Jan 20122:38 pmRNSHolding(s) in Company
23rd Jan 20127:01 amRNSTrading update
12th Jan 201212:13 pmRNSHolding(s) in Company
15th Dec 201111:02 amRNSHolding(s) in Company
30th Nov 20115:23 pmRNSTotal Voting Rights
28th Nov 20117:00 amRNSInterim Results
14th Nov 20112:03 pmRNSIssue of Equity
6th Oct 20117:00 amRNSTrading Update
4th Oct 20112:45 pmRNSHolding(s) in Company
8th Sep 20115:22 pmRNSResult of AGM
8th Sep 20117:00 amRNSAGM Statement
31st Aug 20114:35 pmRNSPrice Monitoring Extension
30th Aug 20117:00 amRNSDirectorate Change
25th Jul 20117:00 amRNSDirectorate Change
29th Jun 20114:50 pmRNSExercise of Options & Total Voting Rights
27th Jun 20117:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.